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SINTESIS HIDROKSIAPATIT DITUKARGANTI KARBONAT MENERUSI 
KAEDAH PENGAKTIFAN MEKANIK 
ABSTRAK 
 
Kaedah pengaktifan mekanik telah dipilih untuk menghasilkan serbuk 
hidroksiapatit ditukarganti karbonat (CHAp) dengan menggunakan CaHPO4.2H2O 
dan CaCO3 sebagai bahan mula. Nisbah mol kalsium-fosforus (Ca/P) bahan-bahan 
tindakbalas adalah 1.67. Pengempaan telah dilakukan dalam suatu bekas agat 
(dengan bebola agat) tertutup dengan pelbagai parameter untuk mengoptimumkan 
proses. Keputusan menunjukkan bahawa kecekapan proses ditentukan oleh tempoh 
kempa, nisbah berat bebola-serbuk (BPR), halaju kempa dan persekitaran kempa. 
Parameter optimum adalah tempoh kempa 24 jam, BPR sebanyak 10:1, halaju kempa 
400 rpm dan kempa kering. Berasaskan parameter optimum ini, pengempaan 
seterusnya bahan mula pada nisbah Ca/P 1.85 dan 2.00 telah dikaji bagi menilai 
kesan kandungan karbonat ke atas sifat CHAp. Kajian terma ke atas serbuk CHAp 
dengan kandungan karbonat berlainan mengesahkan bahawa penukargantian ion 
karbonat untuk kumpulan fosfat meningkatkan kestabilan terma apatit. Padatan 
CHAp juga telah dihasilkan menerusi kaedah penekanan serbuk. Ini dituruti dengan 
pengkarbonatan (pada suhu bilik) dan olahan haba (pada suhu tinggi) untuk 
menghasilkan blok bioseramik bagi kegunaan seterusnya. Hasil kajian menunjukkan 
bahawa padatan yang diperolehi menerusi pengkarbonatan menerusi pengkarbonatan 
mempamerkan kebioaktifan yang cemerlang tetapi kekuatan mekanik yang lemah. 
Olahan haba ke atas padatan CHAp dengan nisbah Ca/P 1.67 didapati tidak sesuai 
untuk menghasilkan blok bioseramik kerana kebioaktifan didapati menurun. Oleh itu, 
CHAp 1.67 boleh digunakan sebagai simen apatit contohnya, yang boleh set dan 
mengeras ditapak kecacatan pada suhu rendah. Padatan CHAp 1.85 dan CHAp 2.00 
yang diolah haba menunjuknya sifat mekanik yang memadai dan kebioaktifan yang 
baik. Namun kekuatan mekanik ini masih tidak memadai bagi kegunaan menampung 
beban. CHAp dengan Ca/P 1.85 dan 2.00 boleh melalui proses olah haba tanpa 
menjejaskan sifat kebioaktifan. Oleh itu, kegunaannya lebih sesuai untuk menyalut 
implan logam atau sebagai implan bukan struktur, contohnya ―ossicles‖ telinga.   
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SYNTHESIS OF CARBONATE-SUBSTITUTED HDROXYAPATITE BY A 
MECHANICAL ACTIVATION METHOD 
ABSTRACT 
 
A mechanical activation method was used to produce a carbonate-substituted 
hydroxyapatite powder (CHAp) using CaHPO4.2H2O and CaCO3 as starting 
materials. The calcium-to-phosphorous molar (Ca/P) ratio of reactants was 1.67. 
Milling was performed in a sealed agate vials and balls with various parameters to 
optimize the process. The results showed that processing efficiency was governed by 
milling time, ball-to-powder weight ratio (BPR), milling speed and milling 
environment. The optimum parameters are as follows: milling duration of 24 hours, 
BPR of 10:1, milling speed of 400 rpm and dry milling. Based on these optimum 
parameters, subsequent milling of reactants at Ca/P ratios of 1.85 and 2.00 were also 
investigated to evaluate the effect of carbonate content on the properties of CHAp. 
Thermal behaviour of CHAp powders with different carbonate contents depicted that 
the substitution of carbonate ions for phosphate group enhanced the thermal stability 
of apatite. Bulk CHAp was prepared by a pressing method, followed by carbonation 
(at room temperature) and heat treatment (at elevated temperature) to produce a 
bioceramic block from the powder for further application. Based on the results 
obtained, bulks prepared by the carbonation method showed excellent bioactivity but 
insufficient mechanical strength. For bulk CHAp with initial Ca/P 1.67, heat 
treatment above 700
o
C was not preferable for fabrication of bioceramic parts because 
the bioactivity was reduced. Thus, CHAp 1.67 could be used as apatite cement, for 
example, which could be set and harden at the bone defect at low temperature. Heat-
treated bulk CHAp 1.85 and CHAp 2.00 showed adequate mechanical properties and 
good bioactivity. However, their mechanical strength was still insufficient for load-
bearing applications. CHAp with initial Ca/P 1.85 and 2.00 could undergo heat 
treatment without reducing the bioactivity properties and thus their application would 
be more appropriate for coating metallic implants or as non-structural implants, i.e.  
ossicles in the ear.  
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CHAPTER I 
INTRODUCTION 
1.1 Background and Problem Statement 
 Large bone defects still represent a major problem in orthopaedics. Dental 
and orthopaedic treatments require sufficient bone and therefore interest in bone 
regeneration is increasing. Bone mineral is calcium phosphate based with a structural 
similarity to hydroxyapatite (HAp). Synthetic HAp with a stoichiometric composition 
Ca10(PO4)6OH)2 has been widely used as bone graft substitute because of its 
biocompatibility, bioactivity and osteoconductivity (LeGeros et al, 2006). However, 
stoichiometric HAp has a limited ability to form an interface with, and to stimulate 
the development of, new bone tissue. Stoichiometric HAp also does not degrade 
significantly but rather remains as a permanent fixture susceptible to long-term 
failure (Ishikawa, 2003). 
 
LeGeros (1994) suggested that carbonate-substituted hydroxyapatite (CHAp) 
is superior to pure HAp for bioresorbable implants. Bone apatite with a carbonate 
content is of 4 – 8 wt% (Vallet-Regi and Gonzalez, 2004) and the calcium-to-
phosphorous molar (Ca/P) ratio is 1.7-2.6 (LeGeros et al, 1993) has better bioactivity 
and osteoconductivity. The presence of carbonate in the apatite lattice is known to 
increase chemical reactivity and would probably contribute to the facilitate 
resorption in bony tissue (Vallet-Regi and Gonzalez, 2004). Two carbonate- 
substituted hydroxyapatites differ in the mode of substitution in the stoichiometric 
hydroxyapatite as described by LeGeros (1969) as A-type (CO3 for OH) or B-type 
(CO3 for PO4).  
2 
 
Associated with its biological importance, CHAp has been widely studied 
recently. A key target of biomaterials research therefore is the preparation of a 
synthetic CHAp bone-substitute ceramic that mimics the chemical composition of 
hard tissue. The preparation of carbonate-substituted hydroxyapatite ceramics must 
be easy and reproducible for it to achieve commercial exploitation and result in a 
new range of biomedical implants materials. Several studies were used to produce 
CHAp and these were classified into two groups such as the wet and dry processes 
according to the processing method. The drawback of a wet process lies in the 
composition of the resulting product which is greatly affected by even a slight 
difference in the reaction conditions (Silva et al, 2004). Moreover, in a wet process, 
the operations require accurate pH adjustment and reaction temperature control of 
solutions. Calcination and drying steps are involved in a wet process after synthesis 
to eliminate moisture and the presence of synthesis residues such as nitrous species. 
Thus, the handling of material and the operation of the apparatus become 
complicated so they cause poor reproducibility and high processing cost.  
 
 Mechanical activation method is an alternative route to produce CHAp 
during which a solid-state reaction is activated by mechanical force. If the 
mechanochemical method involves only a solid state reaction, it should be clearly 
distinguished from the mechanical-hydrothermal synthesis (wet mechanochemical 
method) which incorporates an aqueous phase in the system. Besides, although it is 
categorized as a dry synthesis, this method should be differentiated from solid state 
reaction. The chemical reaction in a solid state reaction is induced by thermal process 
at high temperature, whereas for mechanosynthesis, the chemical reaction is induced 
by the mechanical force (Aaron, 2005). The powder obtained by dry 
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mechanosynthesis can be used directly, without filtering and drying stages, to 
prepare bioceramics. In constrast to the wet processes, it has a lot of well-known 
inherent advantages because of being both an economical and technically simple 
approach to perform mass productivity, and the tremendous flexibility to generate 
nanocrystalline powders (Suryanarayana, 2004; Coreno et al, 2005 and El Briak-
BenAbdeslam, 2008). 
 
Heat treatments are used to prepare dense and porous bioceramics or to coat 
metallic implants by plasma spraying. Heat treatment of CHAp results not only in 
carbonate loss but also in the formation of secondary phases so a crucial 
consideration when sintering CHAp is the thermal stability of the phases. So far, 
previous studies reported that the thermal stability of CHAp varies and depends on 
the carbonate content, the substitution type, heating rate and the heat treatment 
atmosphere (Bigi et al, 1997; Merry et al, 1998; Barralet et al, 2000 and Slosarczyk 
et al, 2005). Generally, the CHAp must be thermally stable such that it will not 
decompose to undesirable secondary phases upon heat treatment. Also, during heat 
treatment, the CHAp must not loose the carbonate that has been substituted into the 
HAp structure in order to retain the bioactivity property of CHAp.  
 
 
In this research, the possibility of using the mechanical activation technique 
to prepare pure CHAp is studied. The preparation of bulk CHAp was carried out by a 
pressing method, followed by both carbonation and heat treatment methods. 
Carbonation method differs from heat treatment method in creating the interlock 
between particles without supplying thermal energy. In carbonation method, bulk 
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CHAp was prepared at room temperature so it could prevent the loss of carbonate 
content. Thus, bulk CHAp obtained by carbonation method could keep the excellent 
bioactivity as well as the increase in mechanical properties. On the other hand, in the 
heat treatment method, the high temperature could provide the strong interlocking 
between particles so that bulk CHAp could increase the mechanical strength. 
However, high temperatures make bulk CHAp reduce its bioactivity by the decrease 
in carbonate content. For this reason, it is important to find a temperature at which 
CHAp still retain good bioactivity. In this study, the heat-treated temperatures for 
bulk CHAp were selected from the evaluation of thermal stability of CHAp powder. 
In general, the final target is to find an optimum method to produce CHAp for 
biomedical applications which has appropriate mechanical, physical, chemical as 
well as bioactivity properties. 
 
1.2 Objectives of the Research 
This study is focused on the preparation of CHAp with high performance 
properties which can be applied in biomedical materials technology. Therefore, the 
main objectives are: 
1. To synthesize CHAp which mimics the chemical composition of the natural 
hard tissue by a mechanical activation method. 
2. To investigate the physical and chemical properties as well as the thermal 
stability of as-milled CHAp powder. 
3. To evaluate mechanical, physical, chemical as well as bioactivity properties 
(using stimulated body fluid (SBF)) of bulk CHAp derived from carbonation 
and heat treatment methods. 
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1.3 Project Overview 
In general, the mechanical activation technique is used to synthesize CHAp 
from dicalcium phosphate dihydrate DCPD (CaHPO4.2H2O) and calcium carbonate 
(CaCO3). This technique is selected due to the simple process and low production 
cost. The calcium-to-phosphorous molar (Ca/P) ratio of the reactants is deliberately 
calculated as being equal to the stoichiometric value of 1.67. Various milling 
parameters were investigated in preparing the CHAp powder. Based on the optimum 
milling parameters, the amount of calcium carbonate was varied according to Ca/P 
ratios of 1.85 and 2.00 in order to evaluate the effect of carbonate content on the 
formation and properties of CHAp. The thermal stability of the CHAp powders was 
investigated by varying the heat treatment temperature under CO2 atmosphere in a 
tube furnace. The purpose of using CO2 atmosphere is to retain the carbonate content 
in the CHAp at elevated temperatures. 
 
Subsequently, CHAp powders were used to prepare bulk CHAp by pressing 
method, followed by carbonation and heat treatment methods. The CHAp green 
bodies were prepared by unaxial pressing. Various pressures and carbonation times 
were investigated in the carbonation method. The optimum pressure selected from 
the carbonation method was used to press the pellets for the heat treatment method so 
as to compare the mechanical, physical and bioactivity properties of the two 
methods. Heat treatment of CHAp pellets was done under CO2 atmosphere in the 
range of temperatures at which the carbonate content still remained without signs of 
decomposition. In summary, the scope of the research is presented in Figure 1.1: 
 
 
6 
 
Milling
Powder pressing
Carbonation  Heat treatment  
CaHPO4.2H2O CaCO3
Bioactivity test
(in vitro)
Density and 
porosity
Mechanical test
Characterization
Characterization CHAp powder
Heat treatment 
CHAp powder
Characterization
Bioactivity test
(in vitro)
Density and 
porosity
Mechanical test
Characterization
 
 
 Figure 1.1 Flow chart of the scope of the research.  
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CHAPTER II 
LITERATURE REVIEW 
2.1 Introduction 
The development of new advanced materials for bone tissue repair is one of 
the main challenges in current developed societies.  Large defects and some bone 
fracture need a longer recovery period and sometimes refuse to heal during the 
body‘s natural bone-healing processes.  Bone is especially vulnerable to fracture in 
older people because of a loss of bone density and strength with age. For instance 
around 40% women older than 50 years will suffer an osteoporotic fracture (Vallet- 
Regi, 2006). Dental and orthopaedic treatments require sufficient bone and therefore 
interest in bone regeneration is increasing.  So far, bone implantation materials have 
been used to guide and expand the bone healing tissue, to become integrated within it 
and then subjected to the same remodelling process as the actual bone over the last 
few decades (Bhat, 2005). 
 
Hydroxyapatite (HAp) has been intensely studied in recent years and is the 
most important inorganic constituent of biological hard tissues due to its excellent 
biocompatibility (Hench and Wilson, 1993). However, human bone mineral differs in 
composition from stoichometric HAp because it contains additional ions, of which 
carbonate is the most abundant specie. Introduction of carbonate ions in the HAp 
would increase its dissolution rate in solution and could enhance its osteointegration 
rate (LeGeros, 1994). Thus, carbonate-substituted hydroxyapatite (CHAp) is a 
prospective material for bone healing and represents one of the most remarkable 
accomplishments of biomaterial research. 
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The goal of this review is to provide an overview of structure and properties 
of bone tissue. Subsequently, biomaterials are defined and classified in general. 
Bioceramic materials which are a part of biomaterials will be also discussed 
particularly in this review. The review then described more detail about calcium 
phostphate materials especially hydroxyapatite and carbonate-substituted 
hydroxyapatite (CHAp). The final part of this review addresses some methods used to 
synthesis CHAp to amplify how the synthesis method, processing step and 
fabrication technique has been utilized in solid-state technology. 
 
2.2 Bone tissue  
Natural bone has long been the object of biomimetic study because of its 
characteristic structure and excellent biomechanical properties. It is important to 
understand this complex structure in detail in order to comprehend how the complex 
process of bone healing occurs when bone fractures heal. Furthermore, it is only by 
understanding the biomechanical and biological properties of bone we can 
understand what type of bone grafts or bone substitutes could be best used to 
reconstruct large defects of normal bone. The best grafts and bone substitutes are 
naturally those with biomechanical and biological properties most closely resembling 
those of normal bone. 
 
Bone is a complex living tissue which has an elegant structure at a range of 
different hierarchical scales. It is basically a composite which is formed by an 
organic matrix with inorganic nanocrystals of apatite phase. The extracellular matrix 
is composed of 50 vol% (or 70 wt%) of inorganic apatite in the form of small, 
nanometer-sized crystallites, and 50 vol% (or 30 wt%) of organic collagen fibres that 
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are fabricated into a three-dimensional structure (Kobuko et al, 2003), as shown in 
Figure 2.1. 
 
 
 
Figure 2.1 Cortical or compact bone and trabecular or spongy bone. Arrangement of 
carbonate- substituted hydroxyapatite and collagen in the formation of hard tissues.  
(Vallet-Regi and Gonzalez, 2004) 
 
 
Biological apatite is identified as an impure HAp. Besides the main ions Ca
2+
, 
PO4
3-
 and OH
-
, the composition of biological apatites always includes CO3
2-
 and also 
a series of minority ions, usually including Mg
2-
, Na
-
, K
-
, Cl
-
, F
-
 . The composition of 
apatites in human enamel, dentin and bone is shown in Table 2.1 (LeGeros, 1994). 
The carbonate hydroxyapatite of bones ranges between 4% and 8% in carbonate 
content, which increases with age while the hydrogen phosphate ion decreases. The 
crystals are nanometer sized, with an average length of 50 nm, 25 nm in width and 
carbonate- substituted 
hydroxyapatite 
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thicknesses of just 2–5 nm, scattered in the organic matrix (as shown in Figure 2.1). 
This mineral component gives rise to the compressive strength of bone (Vallet-Regi 
and Gonzalez, 2004). Bone also contains bone-forming cells (osteoblasts) and bone-
resorbing cells (osteoclasts) and various osteoinductive growth factors and molecules 
(LeGeros, 2006).  
 
Table 2.1 Composition of of apatites in human enamel, dentin and bone. 
 (LeGeros, 1994). 
 
 
 
Composition (% wt) 
 
Enamel Dentin Bone 
Calcium, Ca
2+
 36.5 35.1 34.8 
Phosphorous, P 17.7 16.9 15.2 
Sodium, Na
+
 0.5 0.6 0.9 
Magnesium, Mg
2+
 0.44 1.23 0.72 
Potassium, K
+
 0.08 0.05 0.03 
Carbonate, CO3
2-
 3.5 5.6 7.4 
Flouride, F
-
 0.01 0.06 0.03 
Chloride, Cl
- 
0.30 0.01 0.13 
Pyrophosphate, P3O7
4-
 0.022 0.1 0.07 
    
Total inorganic (mineral) 97 70 65 
Total organic 1.5 20 25 
Absorbed H2O 1.5 10 10 
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Bone is a rather unique tissue with many functions such as providing the cells 
in the marrow that differentiates into blood cells, acting as a calcium reservoir, 
providing mechanical support for soft tissues and serving as an anchor for the 
muscles that generate motion (Nather et al, 2005). There are two types of bone that 
are of most concern in the use of bioceramics. They are compact or cortical bone and 
cancellous or trabecular (also known as spongy) bone (Carter and Norton 2007) as 
shown in Figure 2.2.   
 
 
Figure 2.2 Longitudinal section showing the structure of long bone. 
 (Carter and Norton 2007). 
 
Cortical (compact) bone refers to the dense hard, calcified bone that forms the 
hard outer ―shell‖ of a bone that surrounds the marrow cavity (Safadi, 2009).  
Cancellous bone, also called trabecular or spongy bone is less dense than the cortical 
bone. It consists primarily of lamellar bone, arranged in packets that make up an 
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interconnected irregular array of plates and rods, called trabeculae, the pore of which 
is filled with a gel-like tissue known as bone marrow (Keaveny, 1998) (Figure 2.3). 
The mechanical properties of trabecular bone are highly dependent on its density. 
Due to its lower density, cancellous bone has a lower modulus of elasticity and 
higher strain to failure than cortical bone (Hench and Wilson, 1993). Table 2.2 gives 
the general mechanical properties of cortical bone and cancellous bone. 
 
Table 2.2 Mechanical properties of cortical bone and cancellous bone. 
(Hench and Wilson, 1993) 
 
Property Cortical bone Cancellous bone 
Compressive strength (MPa) 100-230 2-12 
Flexural, Tensile strength (MPa) 50-150 10-20 
Strain to failure 1-3 5-7 
Young's (Tensile) Modulus (GPa) 7-30 0.5-.005 
 
 
 
Figure 2.3 Cancellous bone. Both the bone and the pores (filled in life with 
marrow fat) are interconnected (Currey, 2008) 
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2.3 Bone graft 
Skeletal defects have been replaced by bone grafts for more than 300 years. 
Bone grafting became an accepted technique in the early part of the 20th century and 
nowadays, an estimated 1.5 million bone grafting operations are performed annually 
in the United States. These operations include a multitude of procedures such as 
spinal fusion, internal fixation of fractures, treatment of bone defects and others 
(Carlisle, 2005).  The most common method involves placing a bone graft, which can 
be derived from the patient (autograft), from a registered bone bank (allograft), from 
other mammalian species (xenograft) or synthetic biomaterial into the defect site 
(LeGeros, 2006). 
 
Autograft refers to bone taken from one anatomic site and transplanted to 
another site in the same individual. Autograft remains the gold standard in bone 
transplantation. It contains hydroxyapatite and collagen as an osteoconductive 
scaffold while stromal cells have osteogenic potential (Long and Ibrahim, 2005). 
Although autogenous bone represents the most common graft substance used in bone 
surgery, there are limitations such as donor site morbidity, limited donor bone 
supply, anatomical and structural problems, and elevated levels of resorption during 
healing (Parikh, 2002). 
 
Allograft bone is another alternative to autograft. The difference with 
autograft is the tissue source is not from the same individual. Allograft bone is 
freeze-dried mineralized or demineralized bone matrix processed from cadaver 
(LeGeros, 2006). Allografts may be cancellous, cortical, or a combination of each. 
Though they are attractive sources, there are several problems encountered in using 
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them, including the risk of disease transmission (the small risk of HIV, hepatitis B, 
hepatitis C and syphilis transmission), immunogenicity, loss of biologic and 
mechanical properties secondary to its processing, increased cost, and non-
availability world-wide due to financial and religious concerns (Parikh, 2002). 
Moreover, allografts are primarily osteoconductive with minimal osteoinductive 
potential, but because the donor cells are eradicated during tissue processing, this 
material is not considered to be osteogenic. Allografts are prepared either by freezing 
or lyophilization (ie, freeze-drying) in order to decrease their antigenicity and permit 
storage for extended periods of time (Whang and Wang, 2003). 
 
Xenograft is bone graft whereby the bone is transferred from other 
mammalian species. Xenograft has the same inherent problems as allografts, and 
being from a different species, it may cause even more pronounced immunological 
problems. Human allograft materials are considered more effective and more widely 
available compared to xenografts at present. Xenografts tend to be less effective than 
allografts despite antigenicity treatment. Antigenicity means the ability of a 
substance to trigger an immune response in a particular organism. Generally, the 
graft must be impregnated with the host marrow. However, it elicits an acute 
antigenic response with a high failure rate (Boneva et al, 2001). 
 
Generally, bone grafting currently mainly relies on the use of natural 
materials often bone from another operation. One of the biggest problems with these 
types of procedure is the limited availability of the natural material and consequently 
there is a need for alternative sources of bone graft material. There is a need for the 
development of chemically synthesised materials with reproducible structures and 
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chemical composition to ensure adequate supply and reproducibility (Best et al, 
2008). 
 
2.4 Biomaterial 
The term biomaterials can be interpreted in many ways. The most commonly 
used term to describe appropriate biological requirements of a biomaterial or 
biomaterials used in medical device is biocompatibility. According to its legal 
definition as frequently referenced in the literature, a biomaterial is a nonviable 
material used in a medical device, intended to interact with a biological system 
(Williams, 1987). Park and Lakes (2007) defined biomaterial as any systemically, 
pharmacologically inert substance or combination of substances utilized for 
implantation within or incorporation with a living system to supplement or replace 
functions of living tissue or organs. Besides, as a simple definition, biomaterial can 
be defined as a synthetic material used to replace part of a living system or to 
function in intimate contact with living tissues (Wong and Bronzino, 2007).  Thus, in 
general, materials that interface with biological entities and are used to create 
prosthesis, medical devices and replace natural body tissue are broadly called as 
biomaterials. 
 
Application of biomaterials in medicine has a longer history. The earliest 
record of an application of metal in surgical procedures is as far back as the year 
1565. However, most early medical implants were doomed to failure because 
important concepts relating to infection, materials, and the biological reaction to 
materials were not yet established. The modern implant developments, which 
centered on repairing long bones and joints, began at the end of nineteenth century 
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(Bhat, 2005). In general, biomaterials development was dominated by the 
characteristics of the materials intended for prostheses and medical devices from 
1950 to 1975. Important in the early days was the long-term integrity of the 
biomaterial as well as its non-toxic nature. In the 1980‘s, the revolution in techniques 
for the study of cell and molecular biology led to their application to the 
investigation of interactions occurring at biomaterial interfaces. More recently, with 
the advent of the areas of tissue engineering and regenerative medicine, heavy 
emphasis has been placed on biological interactions with biomaterials (Anderson, 
2006). 
 
The selection and application of synthetic materials for surgical implants has 
been directly dependent upon the biocompatibility profiles of specific prosthetic 
devices. Biocompatibility was defined as the ability of a material to perform with an 
appropriate response in a specific application (Williams, 1987).  The 
biocompatibility of biomaterials is important because implants and tissue interfacing 
devices can corrode in an in vivo environment. The corrosion of the implant can lead 
to loss of load-bearing strength and consequent degradation into toxic products 
within the tissue (Desai et al, 2008). Thus, it is necessary to seek for novel synthesis 
routes by which ideal materials can be developed with required bioactivity, porosity, 
microstructure, and mechanical properties. 
 
Biomaterials can be broadly categorized under the four categories namely: 
polymers, metals, ceramics and composites. Table 2.3 summarizes the advantages 
and disadvantages of each category of biomaterials as well as several common 
applications of them. 
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Table 2.3 Class of materials used in implants (Bhat, 2005).  
 
 
Materials Advantages Disadvantages Common application 
 
Polymers 
Polyolefins, 
Polyesters, 
Silicon rubber. 
 
Low density 
Easy to fabricate 
 
Low mechanical 
strength;  
Additives, oligomers 
may cause tissue 
reaction 
 
Cardiovascular, 
maxillofacial, soft 
skeletal tissue, sutures, 
tissue adhesives, 
percutaneous devices, 
drainage tubes, shunts, 
drug delivery systems 
 
 
Metals 
Stainless steel 
Cobalt-
chromium, 
Titanium alloys. 
 
 
High impact 
strength, 
High resistance 
to wear ductile, 
absortion of high 
strain energy. 
 
Low 
biocompatibility, 
corrosion in 
physiological 
environment, 
mismatch for 
mechanical 
properties with soft 
connective tissues 
 
Orthopedic load 
bearing and fixation 
devices, dental 
implants. 
 
 
 
 
 
Pt, Pt-Ir alloy 
 
High 
conductivity 
 
Low mechanical 
strength, high cost 
 
Neuromuscular 
stimulation 
 
 
Ceramics 
Alumina, 
Zirconia 
 
 
 
Calcium 
phosphates 
 
Good 
biocompatibility, 
inert, corrosion 
resistance, high 
tensile strength, 
 
Biodegradable 
 
 
Undesirable surface 
properties, special 
techniques are need 
for material 
fabrication, 
 
 
Degradation not 
controllable 
 
Hip and Knee 
prosthese, dental 
implants, improving 
biocomaplity. 
 
 
Temporary support, 
assist regeneration of 
natural tissues. 
 
 
Composites  
(carbon-carbon, 
wire- or fiber- 
reinforced bone 
cement) 
(Wong and 
Bronzino, 2007) 
 
Strong, tailor-
made 
 
Difficult to make 
 
Bone cement, dental 
resin 
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The mechanical properties (e.g., strength, modulus, and fatigue limit) of 
metals make them desirable choices for many load-bearing biomedical prostheses 
applications. Metals are susceptible to degradation by corrosion, a process that can 
release by-products (such as ions, chemical compounds, and particulate debris) that 
may cause adverse biological responses. The properties of polymers depend on the 
composition, structure, and arrangement of their constituent macromolecules. 
Ceramics are attractive biomaterials because they can be either bioinert, bioactive, or 
biodegradable; however, they have serious drawbacks because they are brittle and 
have low tensile strength (Wong and Bronzino, 2007). Thus, in the present and 
future, election of a biomaterial for a specific application must be based on several 
criteria. The physicochemical properties and durability of the material, the desired 
function of the prosthesis, the nature of the physiological environment at the 
organ/tissue level, adverse effects in case of failure, as well as cost and production 
issues must be considered for each specific application. 
 
2.5 Bioceramics 
Ceramics, in general, can be defined as the art and science of making and 
using solid articles composed of inorganic and nonmetallic materials for functional 
applications. Ceramics are refractory, polycrystalline compounds, usually inorganic, 
including silicates, metallic oxides, carbides, nitrides, and various refractory hydrides 
and sulfides (Kingery et al, 1976).  The development of designed and fabricated 
ceramics for the repair and reconstruction of diseased and damaged parts of a body is 
found to improve the quality of life of humans in recent years. Ceramics that can be 
used in a human body are called bioceramics (Hench and Wilson, 1993). 
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The ceramic material must meet or exceed the following desired properties of 
implantable bioceramics in order to be classified as a bioceramic: they should be 
nontoxic, noncarcinogenic, nonallergic, noninflammatory biocompatible and 
biofunctional for its lifetime in the host (Bilotte, 2007). 
 
2.5.1 Classification of Bioceramics 
The types of bioceramics are divided into three broad categories according to 
their chemical reactivity with the environment (i) nearly inert (ii) surface reactive 
(iii) completely resorbable bioceramics. For examble, alumina, zirconia and carbons 
are inert bioceramics. Certain glass ceramics and dense hydroxyapatites are semi-
inert (bioactive), calcium sulfate (plaster of Paris) and calcium phosphates ( 
tricalcium phosphate, carbonated hydroxyapatite) are resorbable bioceramics (Hench, 
1998). A comparison of the relative chemical activity of these different types of 
bioceramics is given in Figure 2.4. 
 
Figure 2.4 Bioceramics can be classified into three subgroups, based on their 
chemical reactivity in a physiological environment (Shackelford, 1999) 
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Relative inert bioceramics, such as alumina (Al2O3), show inherently low 
levels of reactivity which peak on the order of 10
4
 days (over 250 years). Bioactive 
ceramics have a substantially higher level of reactivity, peaking on the order of 100 
days, while resorbable bioceramics have even higher levels of reactivity peaking on 
the order of 10 days (Shackelford, 1999). 
 
2.5.1.1 Almost-inert bioceramics 
When biomaterials are almost inert and the interface is not chemically or 
biologically bonded, there is relative movement, and progressive development of a 
non-adherent fibrous capsule occurs in both soft and hard tissues. The weak interface 
between bioceramics and bone lead to deterioration in function of the implant or of 
the tissue at the interface or of both. The thickness of the non-adherent capsule relies 
on both the material and the extent of relative motion. Almost-inert implant which is 
less compatible will make interfacial movement occur so the fibrous capsule 
becomes thicker and the implant loosens quickly (Hench, 1998). 
 
The most utilized bioinert ceramics are alumina, zirconia, hard porcelain, 
cordierite, sillimanite, etc. They offer very good bological performance associated 
with high mechanical load and high mechanical resistance, particularly to cyclic 
compressive loads. So they are utilized to make parts in which the applied 
compressive load is very high and parts in reciprocal movement which should run 
through sliding. Some carbides and nitrides are useful as is porcelain for dental 
applications (Krajewski and Ravaglioli, 2002). Alumina, because of the ability to be 
polished to a high surface finish and its excellent wear resistance, is often used for 
wear surfaces in joint replacement prostheses. Zirconia, known as tetragonal zirconia 
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polycrystals (TZP), is the material of choice currently for ball heads (Hao and Harris, 
2008).  
 
2.5.1.2 Surface reactive bioceramics 
Hench and Wilson (1993) defined a bioactive material as one that elicits a 
specific biological response at the interface of the material, which results in the 
formation of a bond between tissues and the material.  Bioactive ceramics directly 
attaches to the bone by the formation of a carbonate-substituted hydroxyapatite 
(CHAp) layer on their surface when implanted (Figure 2.5) (Combes and Rey, 2007). 
The thickness of the reaction layer among different materials depends upon their 
solubility (Knabe and Ducheyne, 2008).  
 
 
 
1. Equilibrium of the ceramic surface and the solution. Eventual release of 
mineral ions, adsorption of ions and/or of proteins 
2. Nucleation and growth of a layer of carbonate-substituted hydroxyapatite 
analogous to bone mineral from supersaturated biologic fluids. This layer 
contains a number of bioactive proteins. 
3. Cells go towards the modified surface on which these will settle and 
become differentiated in order to give rise to osteoblasts. 
4. The osteoblasts multiply and colonize the surface of the biomaterial. 
5. The cell layer synthesizes a collagenic organic matrix. 
6. The organic matrix mineralizes and the new bone is deposited. 
 
 
Figure 2.5 Events happening at the surface of a bioactive ceramic leading to 
the formation of a bone tissue (Combes and Rey, 2007) 
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Bioactive bioceramics are available as powders, granules, pellets and blocks 
(dense or porous), as cements, as composites and as coatings on orthopedic and 
dental implants (LeGeros, 2006). Among the bioceramics with bioactive properties, 
only some glass-ceramics, for instance apatite-wollastonite (A-W) glass-ceramics 
have evidenced a good performance in spine and hip surgery of patients with 
extensive lesions or bone defects due to its excellent mechanical strengths and 
capacity of binding to living bone (Best et al, 2008). 
 
2.5.1.3 Resorbable bioceramics 
Resorbable biomaterials are designed to degrade gradually over time and be 
replaced by the natural host tissue and the rate of degradation varies from material to 
material. This leads to a very thin or nonexistent interfacial thickness. Natural tissues 
can repair themselves and are gradually replaced throughout life by a continual 
turnover of cell populations. The role of resorbable bioceramics is to serve as 
scaffolding, permitting tissue infiltration and eventual replacement. Thus, resorbable 
biomaterials are based on the same principles of repair that have evolved over 
millions of year (Hench, 1998). 
 
One of the first resorbable bioceramics used was Plaster of Paris. However, 
variable resorption rates and poor mechanical properties have prevented plaster 
implants from being used widely (Bhat, 2005). For a successful application of this 
kind of materials, the resorption rates must match the repair rates of body tissues, and 
the mechanical performance should also be compatible while regeneration of tissues 
is occurring (Hench and Wilson, 1993). Porous or particulate calcium phosphate 
ceramic materials, such as tricalcium phosphate (TCP), are successful materials for 
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resorbable, hard tissue replacements when only low mechanical strength is required, 
such as in some repairs of the jaw or head (Carter and Norton 2007). Besides, 
carbonate-substituted hydroxyapaite (CHAp) is a safe and convenient implant 
material which aids the regeneration of bone in defects produced by the surgical 
excision of benign bone tumors (Uchida, 1990). 
 
2.5.2 Application of Bioceramics 
Bioceramics are now used in a number of different applications throughout 
the body (Figure 2.6). The ability to bond with bone tissue is a unique property of 
bioceramics. This has led to their wide clinical use in both orthopedics as well as 
dentistry. Bioceramics are used as bone substitute materials for bone grafting and as 
coatings for titanium and its alloy (KoBuko, 2008). Some carbons have been used as 
implant for blood interfacing application such as heart valves. Due to their high 
specific strength as fibers and owing to their biocompatibility, ceramics are also used 
as reinforcing components of composite implant materials and for tensile loading 
applications such as tendons and ligaments (Park, 2008). 
 
Bioceramics, particularly calcium phosphates and bioactive glasses, show 
excellent biocompatibility with not only hard tissues, but also with skin and muscle 
tissues, without any toxic effects (LeGeros, 2006). Unfortunately, their mechanical 
properties are relatively poor when compared with natural hard tissue. Furthermore, 
the bioceramics workability is not good; it is difficult for the surgeon to shape the 
bioceramics when necessary during the surgery (Krajewski and Ravaglioli, 2002).  
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Figure 2.6 Different applications of bioceramics in a human body reconstruction 
(Vallet-Regi, 2006). 
 
The poor mechanical properties of ceramic biomaterial (as shown in Table 
2.4), especially in aqueous environments, limit their applications to small, unloaded 
and lightly-loaded implants, powders, coatings, composites and porous scaffolds for 
tissue engineering, and so on. Among bioceramics, alumina has the highest 
mechanical properties, but its tensile properties are still below those of metallic 
biomaterials. Additional advantageous properties of alumina are its low coefficient of 
friction and wear rate. As a consequence of these properties, alumina has been used 
as a bearing surface in joint replacements (Dee et al, 2002). 
 
 
 
